MedPath

Correlation Between Aqueous Protein Level and Clinical Grading of Flare and Flaremetry.

Not Applicable
Completed
Conditions
Uveitis
Interventions
Procedure: Paracentesis of the anterior chamber
Registration Number
NCT01905579
Lead Sponsor
The Eye Center and The Eye Foundation for Research in Ophthalmology
Brief Summary

The purpose of this study is to compare flaremetry readings with the protein content of the aqueous humor and the clinical grading of flare.

Detailed Description

A total of 20 patients will be included. 10 patients with uveitis and 10 control patients scheduled for phacoemulsification. Each patient will undego complete ophthalmic examination and clinical biomicroscopic grading of the anterior chamber flare applying the SUN working group grading system. Aqueous specimens will be obtained by anterior chamber paracentesis for protein analysis. Each Patient will undego paracentesis and 0.2 ml of aqueous will be obtained. The aqueous sample will be stored at -70°C until the time of analysis for protein content. Objective assessment of flare will be done.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 10 patients with uveitis with cataract
  • 10 patients without uveitis with cataract
  • Inactive inflammation for at least 3 months
Exclusion Criteria
  • Infectious uveitis
  • endophthalmitis
  • cases with corneal scar

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
patients without uveitisParacentesis of the anterior chamberParacentesis of the anterior chamber in patients without uveitis undergoing routine cataract surgery
patients with uveitisParacentesis of the anterior chamberParacentesis of the anterior chamber in Paients with uveitis undergoing cataract surgery
Primary Outcome Measures
NameTimeMethod
compare flaremetry readings with the protein content of the aqueous humorone month

Compare flaremetry readings with the protein content of the aqueous and the clinical grading.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Eye Center

🇸🇦

Riyadh, Saudi Arabia

© Copyright 2025. All Rights Reserved by MedPath